vs

Side-by-side financial comparison of MEDIFAST INC (MED) and PDF SOLUTIONS INC (PDFS). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $62.4M, roughly 1.2× PDF SOLUTIONS INC). On growth, PDF SOLUTIONS INC posted the faster year-over-year revenue change (24.6% vs -36.9%). PDF SOLUTIONS INC produced more free cash flow last quarter ($7.5M vs $-6.6M). Over the past eight quarters, PDF SOLUTIONS INC's revenue compounded faster (22.9% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

PDF Solutions, Inc. is an American multinational software and engineering services company based in Santa Clara, California. The company is listed in the Nasdaq stock exchange under the ticker symbol PDFS.

MED vs PDFS — Head-to-Head

Bigger by revenue
MED
MED
1.2× larger
MED
$75.1M
$62.4M
PDFS
Growing faster (revenue YoY)
PDFS
PDFS
+61.5% gap
PDFS
24.6%
-36.9%
MED
More free cash flow
PDFS
PDFS
$14.2M more FCF
PDFS
$7.5M
$-6.6M
MED
Faster 2-yr revenue CAGR
PDFS
PDFS
Annualised
PDFS
22.9%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
PDFS
PDFS
Revenue
$75.1M
$62.4M
Net Profit
$-48.0K
Gross Margin
69.4%
72.9%
Operating Margin
-10.4%
5.5%
Net Margin
-0.1%
Revenue YoY
-36.9%
24.6%
Net Profit YoY
-108.9%
EPS (diluted)
$-1.64
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
PDFS
PDFS
Q4 25
$75.1M
$62.4M
Q3 25
$89.4M
$57.1M
Q2 25
$105.6M
$51.7M
Q1 25
$115.7M
$47.8M
Q4 24
$119.0M
$50.1M
Q3 24
$140.2M
$46.4M
Q2 24
$168.6M
$41.7M
Q1 24
$174.7M
$41.3M
Net Profit
MED
MED
PDFS
PDFS
Q4 25
$-48.0K
Q3 25
$-2.3M
$1.3M
Q2 25
$2.5M
$1.1M
Q1 25
$-772.0K
$-3.0M
Q4 24
$539.0K
Q3 24
$1.1M
$2.2M
Q2 24
$-8.2M
$1.7M
Q1 24
$8.3M
$-393.0K
Gross Margin
MED
MED
PDFS
PDFS
Q4 25
69.4%
72.9%
Q3 25
69.5%
72.3%
Q2 25
72.6%
71.2%
Q1 25
72.8%
72.9%
Q4 24
74.1%
68.3%
Q3 24
75.4%
73.1%
Q2 24
73.2%
70.6%
Q1 24
72.8%
67.3%
Operating Margin
MED
MED
PDFS
PDFS
Q4 25
-10.4%
5.5%
Q3 25
-4.6%
8.5%
Q2 25
-1.0%
2.2%
Q1 25
-1.1%
-7.4%
Q4 24
0.6%
1.0%
Q3 24
1.5%
4.6%
Q2 24
-4.7%
0.6%
Q1 24
4.5%
-4.7%
Net Margin
MED
MED
PDFS
PDFS
Q4 25
-0.1%
Q3 25
-2.5%
2.3%
Q2 25
2.3%
2.2%
Q1 25
-0.7%
-6.3%
Q4 24
1.1%
Q3 24
0.8%
4.8%
Q2 24
-4.8%
4.1%
Q1 24
4.8%
-1.0%
EPS (diluted)
MED
MED
PDFS
PDFS
Q4 25
$-1.64
$0.00
Q3 25
$-0.21
$0.03
Q2 25
$0.22
$0.03
Q1 25
$-0.07
$-0.08
Q4 24
$0.08
$0.01
Q3 24
$0.10
$0.06
Q2 24
$-0.75
$0.04
Q1 24
$0.76
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
PDFS
PDFS
Cash + ST InvestmentsLiquidity on hand
$167.3M
$42.2M
Total DebtLower is stronger
$67.0M
Stockholders' EquityBook value
$198.9M
$271.0M
Total Assets
$248.0M
$418.7M
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
PDFS
PDFS
Q4 25
$167.3M
$42.2M
Q3 25
$173.5M
$35.9M
Q2 25
$162.7M
$40.4M
Q1 25
$164.6M
$54.1M
Q4 24
$162.3M
$114.9M
Q3 24
$170.0M
$120.2M
Q2 24
$163.5M
$117.9M
Q1 24
$156.4M
$122.9M
Total Debt
MED
MED
PDFS
PDFS
Q4 25
$67.0M
Q3 25
$67.6M
Q2 25
$68.1M
Q1 25
$68.7M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MED
MED
PDFS
PDFS
Q4 25
$198.9M
$271.0M
Q3 25
$214.7M
$264.4M
Q2 25
$216.0M
$257.5M
Q1 25
$211.0M
$249.0M
Q4 24
$210.1M
$246.0M
Q3 24
$207.3M
$240.5M
Q2 24
$205.3M
$232.2M
Q1 24
$211.0M
$225.4M
Total Assets
MED
MED
PDFS
PDFS
Q4 25
$248.0M
$418.7M
Q3 25
$268.2M
$406.4M
Q2 25
$269.3M
$391.1M
Q1 25
$280.0M
$390.0M
Q4 24
$284.2M
$315.3M
Q3 24
$291.2M
$307.4M
Q2 24
$293.5M
$298.0M
Q1 24
$302.8M
$286.8M
Debt / Equity
MED
MED
PDFS
PDFS
Q4 25
0.25×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.28×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
PDFS
PDFS
Operating Cash FlowLast quarter
$-5.3M
$17.3M
Free Cash FlowOCF − Capex
$-6.6M
$7.5M
FCF MarginFCF / Revenue
-8.8%
12.1%
Capex IntensityCapex / Revenue
1.8%
15.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$-8.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
PDFS
PDFS
Q4 25
$-5.3M
$17.3M
Q3 25
$12.1M
$3.3M
Q2 25
$-3.4M
$-5.2M
Q1 25
$3.4M
$8.6M
Q4 24
$-4.9M
$1.6M
Q3 24
$9.1M
$9.3M
Q2 24
$13.1M
$684.0K
Q1 24
$7.3M
$-1.9M
Free Cash Flow
MED
MED
PDFS
PDFS
Q4 25
$-6.6M
$7.5M
Q3 25
$10.8M
$-2.9M
Q2 25
$-4.8M
$-13.8M
Q1 25
$1.9M
$535.0K
Q4 24
$-7.2M
$-4.0M
Q3 24
$7.7M
$5.1M
Q2 24
$11.1M
$-4.6M
Q1 24
$5.4M
$-3.9M
FCF Margin
MED
MED
PDFS
PDFS
Q4 25
-8.8%
12.1%
Q3 25
12.0%
-5.1%
Q2 25
-4.5%
-26.6%
Q1 25
1.6%
1.1%
Q4 24
-6.1%
-8.0%
Q3 24
5.5%
11.0%
Q2 24
6.6%
-11.1%
Q1 24
3.1%
-9.4%
Capex Intensity
MED
MED
PDFS
PDFS
Q4 25
1.8%
15.7%
Q3 25
1.5%
10.8%
Q2 25
1.3%
16.5%
Q1 25
1.3%
17.0%
Q4 24
1.9%
11.3%
Q3 24
1.0%
9.0%
Q2 24
1.1%
12.8%
Q1 24
1.1%
4.9%
Cash Conversion
MED
MED
PDFS
PDFS
Q4 25
Q3 25
2.54×
Q2 25
-1.36×
-4.55×
Q1 25
Q4 24
2.98×
Q3 24
8.04×
4.20×
Q2 24
0.40×
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

PDFS
PDFS

Volumebased$38.0M61%
Other$24.4M39%

Related Comparisons